Related Experiment Video
Updated: Dec 16, 2025

Extraction and Analysis of Taiwanese Green Propolis
Published on: January 7, 2019
Antioxidative and Hypoglycemic Effect of Ta-ermi Extracts on Streptozotocin-Induced Diabetes
Siqun Jing1, Zhengmei Zhao2, Jinzi Wu3
1Yingdong Food College, Shaoguan Unversity, Shaoguan, Guangdong 512005, People's Republic of China.
Introduction:
The purpose of the present study was to reveal the potential positive effect of the Ta-ermi extracts on oxidative stress and streptozotocin (STZ)-diabetic mice and rats treated with Ta-ermi water- and alcohol-extracts.
Methods:
The study was carried out using three experimental model: 1) in vitro experiments whereby Ta-ermi extracts were incubated with free radical generators such as 2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) to evaluate Ta-ermi's antioxidant effects; 2) testing the hypoglycemic effects of Ta-ermi extracts in streptozotocin (STZ)-induced diabetic mice; and 3) testing the beneficial effects of Ta-ermi extracts on mitochondrial complex I function using STZ-diabetic rats.
Results:
In vitro antioxidant experiments showed that both of the extracts could scavenge free radicals and exhibited inhibitory effects on glucosidase and aldose reductase with differential effects between water extract and alcohol extract. In the STZ mouse diabetic model, both the water- and alcohol-extracts attenuated body weight decrease, decreased blood glucose levels in a concentration-dependent manner, improved insulin sensitivity, and increased oral glucose tolerance ability. In the STZ-diabetic rat model, both the water- and alcohol-extracts were found to be able to lower blood glucose levels in the diabetic animals with no effects on body weight changes. Moreover, in the STZ-diabetic rats, both the water- and alcohol-extracts of Ta-ermi could inhibit the increase of mitochondrial NADH/ubiquinone oxidoreductase (complex I) activity in the pancreas and enhanced complex I activity in the liver but showed no effect on lung or kidney mitochondrial complex I.
Discussion:
The present study points to the potential medicinal value of Ta-ermi's water and alcohol extracts in lowering blood glucose and decreasing diabetic oxidative stress. One limitation of our study is that the compound or compounds that actually have this beneficial effect in the extracts remain unknown at this time. Therefore, the future studies should be focused on the identification of the components in the extracts that exhibit anti-oxidative and hypoglycemic effects.
Conclusion:
Taken together, our studies using different experimental paradigms indicate that Ta-ermi extracts possess antioxidant and anti-diabetic properties and may be employed as functional food ingredients for the remission of diabetes.
Insights
Ta-ermi extracts show potential in managing diabetes by reducing oxidative stress and lowering blood glucose levels. Further research is needed to identify the specific active compounds responsible for these beneficial effects.
Area of Science:
- Herbal Medicine
- Pharmacology
- Biochemistry
Background:
- Oxidative stress and hyperglycemia are key factors in diabetes mellitus pathogenesis.
- Streptozotocin (STZ)-induced diabetes models are widely used to study anti-diabetic agents.
- Ta-ermi extracts are being investigated for their potential therapeutic effects in diabetes.
Purpose of the Study:
- To evaluate the antioxidant and anti-diabetic effects of Ta-ermi water and alcohol extracts.
- To assess the impact of Ta-ermi extracts on oxidative stress markers in STZ-diabetic animal models.
- To investigate the effects of Ta-ermi extracts on mitochondrial complex I function in diabetic rats.
Main Methods:
- In vitro antioxidant assays using DPPH and ABTS free radical scavengers.
- Evaluation of hypoglycemic effects in STZ-induced diabetic mice.
- Assessment of mitochondrial complex I activity in STZ-diabetic rat tissues (pancreas, liver, lung, kidney).
Main Results:
- Ta-ermi extracts demonstrated significant in vitro antioxidant activity and inhibited glucosidase and aldose reductase.
- Both extracts attenuated hyperglycemia, improved insulin sensitivity, and enhanced glucose tolerance in STZ-diabetic mice.
- Ta-ermi extracts reduced blood glucose in STZ-diabetic rats, inhibited pancreatic mitochondrial complex I, and enhanced hepatic mitochondrial complex I activity.
Conclusions:
- Ta-ermi water and alcohol extracts possess significant antioxidant and anti-diabetic properties.
- These extracts may serve as functional food ingredients for diabetes management.
- Further studies are required to isolate and identify the specific bioactive compounds responsible for the observed effects.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Dipeptidyl Peptidase 4 Inhibitors
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: Sulfonylureas

